Learn about our latest activities
NOVAST Events
Publication
Announcement
A NOVAST-developed non-cyclic oral contraceptive medication DOLISHALE™, the 40th product developed by NOVAST, receives approval by the US FDA on October 22, 2020.
Tel:+86(513)-8598 8888
Copyright 2022 by NOVAST